DHI

DR Horton
D

DHI

Arincen52/100B

DR Horton cash flow statement 1992–2026

DR Horton's free cash flow over the last twelve months was 3.35B USD: operating cash flow of 3.51B USD less 160.40M USD of capital spending. That is 10.1% of its revenue and 11.71 a share.

Operating cash flow Free cash flow

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
30 Sept 2026
FY2026
30 Sept 2026
FY2025
30 Sept 2025
FY2024
30 Sept 2024
FY2023
30 Sept 2023
FY2022
30 Sept 2022
FY2021
30 Sept 2021
FY2020
30 Sept 2020
FY2019
30 Sept 2019
FY2018
30 Sept 2018
FY2017
30 Sept 2017
Net income
2.94B2.94B3.59B4.76B4.80B5.90B4.19B2.38B1.62B1.46B1.04B
Depreciation and amortization
116.50M116.50M101.30M87.10M91.60M81.40M73.90M80.40M72.00M62.40M54.70M
Stock-based compensation
134.00M134.00M131.00M118.10M111.20M105.10M91.40M77.80M73.20M55.80M59.20M
Change in working capital
-24.20M-24.20M-713.60M-2.92B-728.30M-5.62B-3.85B-1.11B-902.80M-1.25B-858.90M
Change in receivables
0.000.000.000.00-131.60M0.000.000.000.000.000.00
Change in inventory
143.70M143.70M158.10M78.80M-516.40M-5.19B-3.76B-1.06B-591.80M-1.06B-946.70M
Change in payables
256.60M256.60M83.70M19.60M-101.80M1.04B845.10M566.20M126.20M129.10M83.90M
Change in other working capital
-424.50M-424.50M-955.40M-3.02B21.50M-1.47B-938.00M-607.70M-437.20M-319.40M3.90M
Other non-cash items
199.60M199.60M193.80M128.40M80.30M70.40M39.90M-26.20M11.00M40.70M30.90M
Operating cash flow
3.51B3.51B3.42B2.19B4.30B561.80M534.40M1.42B892.10M545.20M435.10M
Operating cash flow growth
+2.52%+2.52%+56.22%-49.12%+666.13%+5.13%-62.41%+59.35%+63.63%+25.30%-29.60%
Capital expenditure
-160.40M-160.40M-137.40M-165.30M-148.60M-148.20M-267.40M-286.80M-224.10M-68.10M-157.30M
Acquisitions
-124.10M-124.10M-53.10M-40.40M-212.90M-271.50M-24.50M-5.40M-311.40M-141.70M-4.10M
Purchases of investments
0.000.000.000.000.000.000.00-4.30M-4.40M-290.80M-8.80M
Sales and maturities of investments
0.000.000.000.000.000.000.004.30M4.40M7.30M6.20M
Other investing
-27.30M-27.30M21.80M15.10M51.30M4.80M39.70M126.10M141.50M495.90M-7.00M
Investing cash flow
-311.80M-311.80M-168.70M-190.60M-310.20M-414.90M-252.20M-166.10M-394.00M2.60M-171.00M
Debt issued (repaid)
8.80M8.80M750.60M894.70M-1.06B572.50M1.08B906.90M93.30M199.50M-410.30M
Shares issued
18.30M18.30M0.0040.30M0.001.70M33.50M0.00100.70M0.000.00
-3.52B-3.52B-4.28B-1.79B-1.23B-1.19B-926.90M-398.60M-499.50M-137.80M-65.70M
Dividends paid
-513.30M-513.30M-494.80M-395.20M-341.20M-316.50M-289.30M-256.00M-223.40M-188.40M-149.60M
Other financing
-103.30M-103.30M-737.10M-3.10M-29.30M126.30M53.80M18.30M139.50M44.20M66.10M
Financing cash flow
-4.11B-4.11B-4.76B-1.36B-2.67B-811.20M-85.10M270.60M-490.10M-82.50M-559.50M
Net change in cash
-917.90M-917.90M-1.51B643.90M1.33B-664.30M197.10M1.53B8.00M465.30M-295.40M
3.35B3.35B3.28B2.02B4.16B413.60M267.00M1.13B668.00M477.10M277.80M
Free cash flow growth
+1.93%+1.93%+62.19%-51.28%+904.71%+54.91%-76.47%+69.88%+40.01%+71.74%-47.77%
Free cash flow margin
10.13%10.13%9.59%5.50%11.72%1.24%0.96%5.59%3.80%2.97%1.97%
Free cash flow per share
11.7111.7110.606.1112.101.170.733.071.771.240.73
Free cash flow per share growth
+10.52%+10.52%+73.55%-49.56%+938.37%+59.71%-76.19%+73.18%+42.24%+69.73%-48.30%
Interest paid
———————————
Income taxes paid
869.40M869.40M1.02B1.67B1.44B1.70B1.14B581.30M488.00M-387.20M446.40M

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about DR Horton's cash flow

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.